Walking and resistance bands show promise for breast cancer recovery
NCT ID NCT07338903
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a 12-week home-based program of walking and resistance band exercises could improve physical fitness, fatigue, and quality of life for 36 breast cancer patients in Indonesia. Participants used pedometers and resistance bands at home, with weekly phone check-ins and hospital visits every four weeks. The goal was to see if this approach is feasible and beneficial in a real-world setting.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- home-based aerobic (walking) and resistance training (therapeutic bands)
- What this could lead to
- If successful, this approach could offer a simple, low-cost way to improve physical fitness and reduce fatigue for breast cancer survivors in Indonesia.
- What could go wrong
- This is a small feasibility study with only 36 participants, so results may not apply to all patients. The exercise program relies on self-motivation and may be hard to maintain long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
36 people
The number who actually took part.
- Started
-
Jan 2022
- Finished
-
Feb 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
17 to 70 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with stage I-III hormone-receptor positive breast cancer * Eastern Cooperative Oncology Group (ECOG) score ≤1 * Had completed primary treatment (e.g., surgery, chemotherapy, and radiotherapy), except for hormonal treatment * Within 5 years of diagnosis * Able to perform moderate-intensity physical activity as determined by their oncologist and care team * Able to read and write in Indonesian * Willing to provide written informed consent. Exclusion Criteria: * Had an ejection fraction of \<50% * Evidence of cardiac disease, severe musculoskeletal problems, or other contraindications for exercise.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr. Sardjito General Hospital
Sleman, Yogyakarta Special Region, 55284, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- A Non-Invasive breast scan aims to find the cause of nipple discharge
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?